Submitted by Anonymous (not verified) on 26 May 2026 - 13:53
Human medicines European public assessment report (EPAR): Poherdy, pertuzumab, Date of authorisation: 23/04/2026, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Poherdy, pertuzumab, Date of authorisation: 23/04/2026, Status: Authorised